Impaired Skeletal Muscle in Patients with Stable Chronic Obstructive Pulmonary Disease (COPD) Compared with Non-COPD Patients

References

• Agusti A, Beasley R, Celli B, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [EB/OL]; 2022. Available from: https://goldcopd.org/2023-gold-report-2/. Accessed July 10, 2023.
   Google Scholar
• Sen R, Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell. 1986;46(5):705–716. doi:10.1016/0092-8674(86)90346-6
   PubMed Web of Science ®Google Scholar
• Abdulai RM, Jensen TJ, Patel NR, et al. Deterioration of limb muscle function during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;197(4):433–449. doi:10.1164/rccm.201703-0615CI
   PubMed Web of Science ®Google Scholar
• Schols AM, Soeters PB, Dingemans AM, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993;147(5):1151–1156. doi:10.1164/ajrccm/147.5.1151
   PubMed Web of Science ®Google Scholar
• Schols AM, Wouters EF, Soeters PB, et al. Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 1991;53(2):421–424. doi:10.1093/ajcn/53.2.421
   PubMed Web of Science ®Google Scholar
• Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–307.e2. doi:10.1016/j.jamda.2019.12.012
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi:10.1093/ageing/afy169
   PubMed Web of Science ®Google Scholar
• Yamada Y, Nishizawa M, Uchiyama T, et al. Developing and validating an age-independent equation using multi-frequency bioelectrical impedance analysis for estimation of appendicular skeletal muscle mass and establishing a cutoff for sarcopenia. Int J Environ Res Public Health. 2017;14(7):809. doi:10.3390/ijerph14070809
   PubMed Web of Science ®Google Scholar
• Xu J, Wan CS, Ktoris K, et al. Sarcopenia is associated with mortality in adults: a systematic review and meta-analysis. Gerontology. 2022;68(4):361–376. doi:10.1159/000517099
   PubMed Web of Science ®Google Scholar
• Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med. 2006;173(1):79–83. doi:10.1164/rccm.200506-969OC
   PubMed Web of Science ®Google Scholar
• L Y, W-G X. Skeletal muscle dysfunction and oxidative stress in patients with chronic obstructive pulmonary disease. Int J Respir Pulm Med. 2010;30:294–297.
   Google Scholar
• L K-Y, M L-J, Q Y. Review on the mechanism of skeletal muscle loss for COPD patients with malnutrition. Chin J Respir Crit Care Med. 2013;12:313–315.
   Google Scholar
• M MC, K LY, Z JX, et al. Current situation and prospect of chronic obstructive pulmonary disease community management in China. Chin Gen Pract. 2020;23(3):251–256.
   Google Scholar
• Xue C, Liu Y, Wang J, et al. Consumption of medium- and long-chain triacylglycerols decreases body fat and blood triglyceride in Chinese hypertriglyceridemic subjects. Eur J Clin Nutr. 2009;63(7):879–886. doi:10.1038/ejcn.2008.76
   PubMed Web of Science ®Google Scholar
• Van De Bool C, Gosker HR, Van Den Borst B, et al. Muscle quality is more impaired in sarcopenic patients with chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2016;17(5):415–420. doi:10.1016/j.jamda.2015.12.094
   PubMed Web of Science ®Google Scholar
• Holland AE, Spruit MA, Troosters T, et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J. 2014;44(6):1428–1446. doi:10.1183/09031936.00150314
   PubMed Web of Science ®Google Scholar
• Sepúlveda-Loyola W, De Castro LA, Matsumoto AK, et al. NOVEL antioxidant and oxidant biomarkers related to sarcopenia in COPD. Heart Lung. 2021;50(1):184–191. doi:10.1016/j.hrtlng.2020.06.001
   PubMed Web of Science ®Google Scholar
• Buford TW, Cooke MB, Manini TM, et al. Effects of age and sedentary lifestyle on skeletal muscle NF-kappaB signaling in men. J Gerontol a Biol Sci Med Sci. 2010;65(5):532–537. doi:10.1093/gerona/glp196
   PubMed Web of Science ®Google Scholar
• Lexell J, Downham D. What is the effect of ageing on type 2 muscle fibres? J Neurol Sci. 1992;107(2):250–251. doi:10.1016/0022-510X(92)90297-X
   PubMed Web of Science ®Google Scholar
• Caram LM, Ferrari R, Bertani AL, et al. Smoking and early COPD as independent predictors of body composition, exercise capacity, and health status. PLoS One. 2016;11(10):e0164290. doi:10.1371/journal.pone.0164290
   PubMed Web of Science ®Google Scholar
• Mason SE, Moreta-Martinez R, Labaki WW, et al. Respiratory exacerbations are associated with muscle loss in current and former smokers. Thorax. 2021;76(6):554–560. doi:10.1136/thoraxjnl-2020-215999
   PubMed Web of Science ®Google Scholar
• Donaldson AV, Maddocks M, Martolini D, et al. Muscle function in COPD: a complex interplay. Int J Chron Obstruct Pulmon Dis. 2012;7:523–535. doi:10.2147/COPD.S28247
   PubMed Web of Science ®Google Scholar
• Schneider LP, Sartori LG, Machado FVC, et al. Physical activity and inactivity among different body composition phenotypes in individuals with moderate to very severe chronic obstructive pulmonary disease. Braz J Phys Ther. 2021;25(3):296–302. doi:10.1016/j.bjpt.2020.07.005
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhong NS, Li X, et al. Tiotropium in early-stage chronic obstructive pulmonary disease. N Engl J Med. 2017;377(10):923–935. doi:10.1056/NEJMoa1700228
   PubMed Web of Science ®Google Scholar
• Wilson DO, Rogers RM, Wright EC, et al. Body weight in chronic obstructive pulmonary disease. The national institutes of health intermittent positive-pressure breathing trial. Am Rev Respir Dis. 1989;139(6):1435–1438.
   PubMed Web of Science ®Google Scholar
• Cao C, Wang R, Wang J, et al. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS One. 2012;7(8):e43892. doi:10.1371/journal.pone.0043892
   PubMed Web of Science ®Google Scholar
• Beijers R, Van De Bool C, Van Den Borst B, et al. Normal weight but low muscle mass and abdominally obese: implications for the cardiometabolic risk profile in chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2017;18(6):533–538. doi:10.1016/j.jamda.2016.12.081
   PubMed Web of Science ®Google Scholar
• Real GG, Frühauf IR, Sedrez JHK, et al. Calf circumference: a marker of muscle mass as a predictor of hospital readmission. JPEN J Parenter Enteral Nutr. 2018;42(8):1272–1279. doi:10.1002/jpen.1170
   PubMed Web of Science ®Google Scholar
• Pagotto V, Santos KFD, Malaquias SG, et al. Calf circumference: clinical validation for evaluation of muscle mass in the elderly. Rev Bras Enferm. 2018;71(2):322–328. doi:10.1590/0034-7167-2017-0121
   PubMed Web of Science ®Google Scholar
• Tresignie J, Scafoglieri A, Pieter Clarys J, et al. Reliability of standard circumferences in domain-related constitutional applications. Am J Hum Biol. 2013;25(5):637–642. doi:10.1002/ajhb.22423
   PubMed Web of Science ®Google Scholar
• Adami A, Corvino RB, Calmelat RA, et al. Muscle oxidative capacity is reduced in both upper and lower limbs in COPD. Med Sci Sports Exerc. 2020;52(10):2061–2068. doi:10.1249/MSS.0000000000002364
   PubMed Web of Science ®Google Scholar